XOMA Royalty Corporation

XOMA · Moat type: REGULIERUNG

MoatScore

5/10

Fair Value

41 USD

Margin of Safety

+1.4 %

Rating

BEOBACHTEN

XOMA Royalty Corporation acquires and holds royalty rights on biopharmaceutical product candidates in clinical development and generates revenues primarily through milestone and licensing fees once these products achieve regulatory approval or cross revenue thresholds.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.